Olive C - Search Results

1

Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines.

Moyle PM, Olive C, Ho MF, Pandey M, Dyer J, Suhrbier A, Fujita Y, Toth I. Moyle PM, et al. Among authors: olive c. J Med Chem. 2007 Sep 20;50(19):4721-7. doi: 10.1021/jm070287b. Epub 2007 Aug 17. J Med Chem. 2007. PMID: 17705361

2

Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies.

Olive C, Toth I, Jackson D. Olive C, et al. Mini Rev Med Chem. 2001 Nov;1(4):429-38. doi: 10.2174/1389557013406666. Mini Rev Med Chem. 2001. PMID: 12369968 Review.

3

Towards the development of a broadly protective group a streptococcal vaccine based on the Lipid-Core Peptide system.

Olive C, Moyle PM, Toth I. Olive C, et al. Curr Med Chem. 2007;14(28):2976-88. doi: 10.2174/092986707782794069. Curr Med Chem. 2007. PMID: 18220734 Review.

4

Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage.

Horváth A, Olive C, Karpati L, Sun HK, Good M, Toth I. Horváth A, et al. Among authors: olive c. J Med Chem. 2004 Jul 29;47(16):4100-4. doi: 10.1021/jm040041w. J Med Chem. 2004. PMID: 15267249

5

Method for the synthesis of multi-epitopic Streptococcus pyogenes lipopeptide vaccines using native chemical ligation.

Moyle PM, Olive C, Ho MF, Burgess M, Karpati L, Good MF, Toth I. Moyle PM, et al. Among authors: olive c. J Org Chem. 2006 Sep 1;71(18):6846-50. doi: 10.1021/jo060960p. J Org Chem. 2006. PMID: 16930036

6

Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation.

Moyle PM, Olive C, Ho MF, Good MF, Toth I. Moyle PM, et al. Among authors: olive c. J Med Chem. 2006 Oct 19;49(21):6364-70. doi: 10.1021/jm060475m. J Med Chem. 2006. PMID: 17034142

7

Method for the synthesis of highly pure vaccines using the lipid core peptide system.

Moyle PM, Olive C, Good MF, Toth I. Moyle PM, et al. Among authors: olive c. J Pept Sci. 2006 Dec;12(12):800-7. doi: 10.1002/psc.815. J Pept Sci. 2006. PMID: 17131293

8

Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines.

Simerska P, Abdel-Aal AB, Fujita Y, Moyle PM, McGeary RP, Batzloff MR, Olive C, Good MF, Toth I. Simerska P, et al. Among authors: olive c. J Med Chem. 2008 Mar 13;51(5):1447-52. doi: 10.1021/jm701410p. Epub 2008 Feb 16. J Med Chem. 2008. PMID: 18278857

9

Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes.

Horvath A, Olive C, Wong A, Clair T, Yarwood P, Good M, Toth I. Horvath A, et al. Among authors: olive c. J Med Chem. 2002 Mar 14;45(6):1387-90. doi: 10.1021/jm0110441. J Med Chem. 2002. PMID: 11882009

10

Lipid core peptide technology and group A streptococcal vaccine delivery.

Olive C, Batzloff MR, Toth I. Olive C, et al. Expert Rev Vaccines. 2004 Feb;3(1):43-58. doi: 10.1586/14760584.3.1.43. Expert Rev Vaccines. 2004. PMID: 14761243 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters